Multigene and multitests: current trend and implications of genetic biomarkers for personalized medicine.

Hu, Sean X; Laing, Rachel E; Ramanathan, Chandra

Hu, Sean X; Laing, Rachel E; Ramanathan, Chandra.

Afiliación

Hu SX; Bionest Partners, 14 Wall Street, 20th Floor, New York, NY 10005, USA and Chinese National Human Genome Center at Shanghai, Chinese Academy of Sciences, Shanghai, China and Beijing Genomics Institute, Beijing, China. shu@bionest.com.
Laing RE; Bionest Partners, 14 Wall Street, 20th Floor, New York, NY 10005, USA.
Ramanathan C; Bayer HealthCare Pharmaceuticals Inc., Montville, NJ, USA.

Per Med ; 9(6): 561-564, 2012 Aug.

Article en En | MEDLINE | ID: mdl-29768794

Palabras clave

biomarker; clinical practice; commercialization model; companion diagnostics; diagnostics; genomic; multigene; multiplex; multitest; personalized medicine; segmentation; targeted medicine

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Per Med Año: 2012 Tipo del documento: Article País de afiliación: China